H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 109 Citations 48,690 368 World Ranking 2530 National Ranking 32

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Gene
  • Mutation

Anne Tybjærg-Hansen spends much of her time researching Internal medicine, Endocrinology, Cholesterol, Odds ratio and Risk factor. Her work deals with themes such as Population study and Cardiology, which intersect with Internal medicine. Her Population study research is multidisciplinary, incorporating elements of Prospective cohort study and Cohort study.

Her Endocrinology research is multidisciplinary, relying on both Mutation and TM6SF2. Her studies deal with areas such as Diabetes mellitus, ANGPTL3 and Niacin as well as Cholesterol. Her Odds ratio research integrates issues from Meta-analysis and Case-control study.

Her most cited work include:

  • Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women (1574 citations)
  • Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study (1555 citations)
  • Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society (1430 citations)

What are the main themes of her work throughout her whole career to date?

Anne Tybjærg-Hansen mainly focuses on Internal medicine, Endocrinology, Disease, Odds ratio and Cardiology. Anne Tybjærg-Hansen works mostly in the field of Internal medicine, limiting it down to topics relating to Population study and, in certain cases, Diabetes mellitus, as a part of the same area of interest. Her Endocrinology research includes elements of Mendelian randomization, Genotype and Risk factor.

The various areas that Anne Tybjærg-Hansen examines in her Disease study include Epidemiology, Bioinformatics and Increased risk. Her biological study spans a wide range of topics, including Gastroenterology, Surgery, Cohort study and Case-control study. Within one scientific family, Anne Tybjærg-Hansen focuses on topics pertaining to Vascular disease under Cardiology, and may sometimes address concerns connected to Ischemia and Pathology.

She most often published in these fields:

  • Internal medicine (86.48%)
  • Endocrinology (42.74%)
  • Disease (24.45%)

What were the highlights of her more recent work (between 2016-2021)?

  • Internal medicine (86.48%)
  • Population study (18.29%)
  • Disease (24.45%)

In recent papers she was focusing on the following fields of study:

Anne Tybjærg-Hansen mainly investigates Internal medicine, Population study, Disease, Endocrinology and Mendelian randomization. Many of her studies involve connections with topics such as Diabetes mellitus and Internal medicine. Anne Tybjærg-Hansen has researched Population study in several fields, including Body mass index, Myocardial infarction and Allele.

Anne Tybjærg-Hansen combines subjects such as Lower risk and Polymorphism with her study of Endocrinology. Her Mendelian randomization research includes themes of Epidemiology, Cohort study, Retinopathy, F2RL3 and Risk factor. Her work focuses on many connections between Hazard ratio and other disciplines, such as Cardiology, that overlap with her field of interest in Lipoprotein.

Between 2016 and 2021, her most popular works were:

  • Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease (322 citations)
  • Exome-wide association study of plasma lipids in > 300,000 individuals (265 citations)
  • Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis (172 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Mutation

Her primary scientific interests are in Internal medicine, Endocrinology, Odds ratio, Genome-wide association study and Genetics. As a member of one scientific family, she mostly works in the field of Internal medicine, focusing on Population study and, on occasion, Dementia and Hazard ratio. As a part of the same scientific study, Anne Tybjærg-Hansen usually deals with the Endocrinology, concentrating on Disease and frequently concerns with PCSK9 and Randomized controlled trial.

The concepts of her Odds ratio study are interwoven with issues in Mendelian randomization and Type 2 diabetes. Her Genome-wide association study research incorporates elements of Genetic association and Bioinformatics. Her study in the field of Allele also crosses realms of Low frequency.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women

Børge G. Nordestgaard;Marianne Benn;Peter Schnohr;Anne Tybjærg-Hansen.
JAMA (2007)

2629 Citations

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

Borge G. Nordestgaard;M. John Chapman;Steve E. Humphries;Henry N. Ginsberg.
European Heart Journal (2013)

2341 Citations

Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study

Benjamin F. Voight;Benjamin F. Voight;Benjamin F. Voight;Gina M. Peloso;Gina M. Peloso;Marju Orho-Melander;Ruth Frikke-Schmidt.
web science (2012)

1870 Citations

Lipoprotein(a) as a cardiovascular risk factor: current status

Børge G. Nordestgaard;M. John Chapman;Kausik Ray;Jan Borén.
European Heart Journal (2010)

1611 Citations

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

M John Chapman;Henry N Ginsberg;Pierre Amarenco;Felicita Andreotti.
European Heart Journal (2011)

1287 Citations

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.

Pia R. Kamstrup;Anne Tybjærg-Hansen;Rolf Steffensen;Børge G. Nordestgaard.
JAMA (2009)

1144 Citations

Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

Anders Berg Jørgensen;Ruth Frikke-Schmidt;Børge G. Nordestgaard;Anne Tybjærg-Hansen.
The New England Journal of Medicine (2014)

908 Citations

Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease

Jeppe Zacho;Anne Tybjærg-Hansen;Jan Skov Jensen;Peer Grande.
The New England Journal of Medicine (2008)

892 Citations

Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

Anette Varbo;Marianne Benn;Anne Tybjærg-Hansen;Anders B. Jørgensen.
Journal of the American College of Cardiology (2013)

824 Citations

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.

Julia Kozlitina;Eriks Smagris;Stefan Stender;Børge G Nordestgaard.
Nature Genetics (2014)

767 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Anne Tybjærg-Hansen

Børge G. Nordestgaard

Børge G. Nordestgaard

Copenhagen University Hospital

Publications: 476

Gerald F. Watts

Gerald F. Watts

University of Western Australia

Publications: 286

George Davey Smith

George Davey Smith

University of Bristol

Publications: 197

Daniel J. Rader

Daniel J. Rader

University of Pennsylvania

Publications: 196

Sekar Kathiresan

Sekar Kathiresan

Harvard University

Publications: 171

Robert A. Hegele

Robert A. Hegele

University of Western Ontario

Publications: 153

Eric Boerwinkle

Eric Boerwinkle

The University of Texas Health Science Center at Houston

Publications: 151

John J.P. Kastelein

John J.P. Kastelein

University of Amsterdam

Publications: 126

Stig E. Bojesen

Stig E. Bojesen

University of Copenhagen

Publications: 121

Mark I. McCarthy

Mark I. McCarthy

University of Oxford

Publications: 121

Winfried März

Winfried März

Heidelberg University

Publications: 118

Nicholas J. Wareham

Nicholas J. Wareham

University of Cambridge

Publications: 118

Steve E. Humphries

Steve E. Humphries

University College London

Publications: 116

Nilesh J. Samani

Nilesh J. Samani

University of Leicester

Publications: 113

John Danesh

John Danesh

University of Cambridge

Publications: 113

Something went wrong. Please try again later.